Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Epac Regulates UT-A1 to Increase Urea Transport in Inner Medullary Collecting Ducts
Journal of the American Society of Nephrology, 08/07/09
Sands JM et al. – Activation of Epac increases urea transport, accumulation of UT–A1 at the plasma membrane, and UT–A1 phosphorylation, the latter of which is mediated by the MEK–ERK pathway.
Jeff M. Sands, 08/07/09
| Urea and urea transporters play key roles in the urinary concentrating mechanism within the renal inner medulla. Vasopressin is the primary hormone regulating the urine concentrating mechanism. Vasopressin is traditionally thought to act via cAMP to stimulate PKA. The major finding in this study is the identification of a second pathway by which vasopressin and cAMP stimulate urea transport: the Epac pathway. Epac activation results in a functional change in urea transport in perfused rat terminal IMCDs. The increase in urea transport results, at least in part, from Epac-stimulated increases in UT-A1 phosphorylation and plasma membrane accumulation. To our knowledge, this is the first demonstration that the Epac pathway regulates urea transport in the kidney. |
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
Cancer Research, 11/03/09
Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1
Human Molecular Genetics, 11/03/09
Mesenchymal Stem Cell Homing Capacity
Transplantation, 10/29/09
Today in Glomerular/Tubular Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
Change in Estimated GFR Associates with Coronary Heart Disease and Mortality
Journal of the American Society of Nephrology, 11/23/09
Biomarkers for Lupus Nephritis: The Quest Continues
Clinical Journal of the American Society of Nephrology, 11/13/09
Article Search
Sponsor


See Latest Articles


